BMJ 2003;326:559-560 ( 15 March )

Editorials

Efficacy of albumin in critically ill patients

Large trial in Australia and New Zealand may provide an answer

The first 150 words of the full text of this article appear below.

In 1998, the BMJ published a meta-analysis that compared the effects of fluids containing albumin and crystalloids on death rates in critically ill patients.1 The analysis included 24 studies involving 1419 patients. The report concluded that there was no evidence that albumin reduced mortality and a strong implication that it might increase the risk of death. The authors recommended that use of albumin in critically ill patients be reviewed urgently and that albumin should not be used outside the context of rigorously conducted randomised controlled trials. Despite the fact that the reviewers themselves advised that their results must be interpreted with caution, an accompanying editorial called for a total halt to the use of albumin in critically ill patients.2 In the following weeks, numerous editorials and letters published in the BMJ debated the various merits of using albumin, without reaching consensus.3-6

As we approach the fifth anniversary of the original meta-analysis, no . . . [Full text of this article]
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Doig, G. S., Simpson, F., Delaney, A. (2005). A Review of the True Methodological Quality of Nutritional Support Trials Conducted in the Critically Ill: Time for Improvement. Anesth. Analg. 100: 527-533 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Albumin and Nutrition
Kamal Kumar Mahawar
bmj.com, 15 Mar 2003 [Full text]
Relevance in the trauma population?
ULISES TORRES, et al.
bmj.com, 6 Jun 2005 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ